Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

The Lancet Oncology

Fecha de publicación: December, 2020

DOI: https://doi.org/10.1016/S1470-2045(20)30527-1

Autores: Marjukka Pollari, Teijo Pellinen, Marja ‐ Liisa Karjalainen ‐ Lindsberg, Pirkko ‐ Liisa Kellokumpu ‐ Lehtinen, Suvi ‐ Katri Leivonen, Sirpa Leppä

Background: A prospective, pooled analysis of six randomised phase 3 trials was done to investigate disease-free survival regarding non-inferiority of 3 months versus 6 months of adjuvant chemotherapy for patients with stage III colon cancer; non-inferiority was not shown. Here, we report the final overall survival results.

Leer más